Regulation & Compliance

A new partnership between Apex Fintech Solutions and Allfunds aims to dismantle barriers to offshore investing, creating a streamlined gateway for global funds.

A new report finds 90% of nurses miss key updates due to flawed communication, leading to patient care errors and fueling the nursing staff crisis.

With survey fraud costing millions, Rep Data appoints a former Kantar CIO and Research Defender's founder to sharpen its tech and product focus.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

BEGA's new BEGA Connect platform leverages cloud power and NB-IoT to simplify architectural lighting control, eliminating servers and subscription fees.

The cybersecurity firm renewed its multi-million dollar GRC contract with a Fortune 100 client, signaling deep trust and validating its market strategy.

A new report challenges raid-focused tactics, using survivor stories to offer a blueprint for preventing exploitation in America's illicit massage industry.

Quantum PKI appoints Dr. Judy Gounden as CEO, signaling a strategic push for global growth, crypto-agility, and diverse leadership in digital trust.

With a key FDA meeting set, Trevi Therapeutics pushes its drug Haduvio into late-stage trials, offering hope for millions with no approved treatments.

With nearly $30M in new funding, fintech firm Obita is building a blockchain-based network to tackle the high costs and delays of global B2B transactions.

A new vectorized antibody therapy for ALS, VTx-002, has been granted FDA Fast Track status, accelerating its path to patients battling the disease.

Replicate Bioscience secures major funding to develop next-gen self-replicating RNA vaccines, aiming for more durable and accessible global health solutions.

AI data platform Protege raises its Series A to $65M, tackling the critical data bottleneck with an ethical, licensing-first model for real-world data.

How a blend of private capital and pragmatic regulation is turning Singapore into a global hub for longevity research, pushing scientific and ethical boundaries.

A landmark partnership with Open Campus will use blockchain to combat fraud, boost employability, and create a verifiable digital credential system for millions.

Oculis is advancing a neuroprotective drug for optic neuropathies and a first-of-its-kind eye drop for diabetic macular edema, aiming at $10B+ markets.

Webull's new Vega AI offers institutional-grade analysis at no cost, shaking up the competitive brokerage market and raising questions for regulators.

SNDL finalizes the first phase of a major retail acquisition from 1CM, signaling deeper market consolidation and a strategic push into Ontario's market.

Dexcel Pharma USA acquires Zubsolv®, a key opioid addiction therapy, signaling a major strategic shift into the branded drug market in the U.S.

CMS withdraws a controversial rule, ensuring patient access to advanced wound care, but a new payment model still looms over the MedTech industry.